Neo Ivy Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.02M	Buy	+60,833	New	+$1.81M	0.53%	75
2025 Q2	–	Sell	-6,790	Closed	-$268K	–	472
2025 Q1	$268K	Buy	+6,790	New	+$228K	0.09%	216
2024 Q4	–	Sell	-100,780	Closed	-$2.36M	–	400
2024 Q3	$2.36M	Buy	+100,780	New	+$2.2M	0.76%	44
2023 Q3	–	Sell	-15,099	Closed	-$375K	–	452
2023 Q2	$375K	Buy	+15,099	New	+$390K	0.2%	147
2021 Q4	–	Sell	-5,209	Closed	-$101K	–	625
2021 Q3	$101K	Sell	5,209 -2,495	-32%	-$77.2K	0.12%	245
2021 Q2	$299K	Buy	7,704 +5,635	+272%	+$221K	0.3%	127
2021 Q1	$100K	Sell	2,069 -418	-17%	-$20.1K	0.11%	244
2020 Q4	$129K	Sell	2,487 -2,721	-52%	-$91.9K	0.14%	220
2020 Q3	$139K	Sell	5,208 -1	-0%	-$23	0.14%	240
2020 Q2	$101K	Buy	+5,209	New	+$83.9K	0.12%	245